Trillium Therapeutics shares soar on Pfizer’s $2.26B deal | Fox Business

Pfizer’s $2.26B Trillium deal will target drugs for blood cancers, such as leukemia, multiple myeloma and lymphoma, according to the companies.

Source: Trillium Therapeutics shares soar on Pfizer’s $2.26B deal | Fox Business